Cargando…

Dynamic Chromatin Modification Sustains Epithelial-Mesenchymal Transition following Inducible Expression of Snail-1

Epithelial-mesenchymal transition (EMT) is thought to contribute to cancer metastasis, but its underlying mechanisms are not well understood. To define early steps in this cellular transformation, we analyzed human mammary epithelial cells with tightly regulated expression of Snail-1, a master regul...

Descripción completa

Detalles Bibliográficos
Autores principales: Javaid, Sarah, Zhang, Jianmin, Anderssen, Endre, Black, Josh C., Wittner, Ben S., Tajima, Ken, Ting, David T., Smolen, Gromoslaw A., Zubrowski, Matthew, Desai, Rushil, Maheswaran, Shyamala, Ramaswamy, Sridhar, Whetstine, Johnathan R., Haber, Daniel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034764/
https://www.ncbi.nlm.nih.gov/pubmed/24360956
http://dx.doi.org/10.1016/j.celrep.2013.11.034
Descripción
Sumario:Epithelial-mesenchymal transition (EMT) is thought to contribute to cancer metastasis, but its underlying mechanisms are not well understood. To define early steps in this cellular transformation, we analyzed human mammary epithelial cells with tightly regulated expression of Snail-1, a master regulator of EMT. After Snail-1 induction, epithelial markers were repressed within 6 hr, and mesenchymal genes were induced at 24 hr. Snail-1 binding to its target promoters was transient (6–48 hr) despite continued protein expression, and it was followed by both transient and long-lasting chromatin changes. Pharmacological inhibition of selected histone acetylation and demethylation pathways suppressed the induction as well as the maintenance of Snail-1-mediated EMT. Thus, EMT involves an epigenetic switch that may be prevented or reversed with the use of small-molecule inhibitors of chromatin modifiers.